Login
Login
切换导航
Home
Articles
Journals
Books
News
About
Services
Submit
Home
Journal
Articles
Journals A-Z
Browse Subjects
Biomedical & Life Sci.
Business & Economics
Chemistry & Materials Sci.
Computer Sci. & Commun.
Earth & Environmental Sci.
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sci. & Humanities
Browse Subjects
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Earth & Environmental Sciences
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Complete Matching
Editorial Board
Show/Hide Options
Show/Hide Options
All
Title
Abstract
Keywords
DOI
Author
Journal
Affiliation
ISSN
Subject
Bortezomib-Induced Multiple Chalazia: A Case Report
(Short Report)
Rania Mohamed
,
Horace Massa
,
Claude Schwarz
,
Nicole Grandjean-Hallez
,
Kaveh Samii
Case Reports in Clinical Medicine
Vol.4 No.1
,January 19, 2015
DOI:
10.4236/crcm.2015.41008
3,281
Downloads
4,224
Views
Citations
The Efficacy and Safety of a 1.6 mg/m
2
Increase in a Bortezomib Regimen
(Articles)
Sohsuke Meshitsuka
,
Kenshi Suzuki
Open Journal of Blood Diseases
Vol.5 No.1
,February 27, 2015
DOI:
10.4236/ojbd.2015.51001
4,640
Downloads
5,738
Views
Citations
Inhibition of proteasome by bortezomib increase chemosensitivity of bcr/abl positive human k562 chronic myleoid leukemia cells to imatinib
(Articles)
Baran Yusuf
,
Coskun Oztekin
,
Bassoy Esen Yonca
Health
Vol.1 No.4
,December 31, 2009
DOI:
10.4236/health.2009.14052
6,113
Downloads
11,731
Views
Citations
Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN
(Articles)
Maria E. Rich
,
Ping Zhao
,
Abhinav B. Nagulapally
,
Jeffrey Bond
,
Giselle L. Saulnier Sholler
Journal of Cancer Therapy
Vol.8 No.6
,June 21, 2017
DOI:
10.4236/jct.2017.86048
1,449
Downloads
2,933
Views
Citations
Bortezomib-Induced Bilateral Eye Swelling and Cutaneous Adverse Reaction in a Patient with Plasma Cell Leukemia—A Case Report
(Articles)
Azeezat Ariwoola
,
Ehab A. M. Elagab
,
Tahira Fardous
,
Saburi Oyewale
,
Sara Parisi
,
Heather Williams
,
Amal M. Shediwah
,
Islam A. Mahmoud
,
Ratesh Khillan
Case Reports in Clinical Medicine
Vol.12 No.11
,November 9, 2023
DOI:
10.4236/crcm.2023.1211061
58
Downloads
398
Views
Citations
Pancreatic Neuroendocrine Tumors Are Characterized by Loss of
Noxa
Expression that Can be Recovered by the Proteasome Inhibitor Bortezomib
(Articles)
E. P. Slater
,
J. Waldmann
,
C. López
,
E. Matthäi
,
V. Fendrich
,
D. K. Bartsch
Journal of Cancer Therapy
Vol.4 No.10A
,November 14, 2013
DOI:
10.4236/jct.2013.410A004
2,875
Downloads
4,428
Views
Citations
This article belongs to the Special Issue on
Pancreatic Cancer Research
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Home
Journals A-Z
Subject
Books
Sitemap
Contact Us
About SCIRP
Publication Fees
For Authors
Peer-Review Issues
Special Issues
News
Service
Manuscript Tracking System
Subscription
Translation & Proofreading
FAQ
Volume & Issue
Policies
Open Access
Publication Ethics
Preservation
Retraction
Privacy Policy
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top